2019
DOI: 10.1136/bcr-2018-229122
|View full text |Cite
|
Sign up to set email alerts
|

Malignant deep brain stimulator withdrawal syndrome

Abstract: Parkinsonism-hyperpyrexia syndrome (PHS) is a neurologic potentially fatal emergency that mimics neuroleptic malignant syndrome. It commonly presents as systemic inflammatory response syndrome, acute onset worsening of muscular rigidity, autonomic instability, hyperpyrexia, confusion, diaphoresis and high creatine phosphokinase. The most common trigger for PHS is reduction or withdrawal of anti-Parkinson’s medications, especially levodopa. It was also reported in a few cases following deep brain stimulation of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 23 publications
(21 reference statements)
0
20
0
Order By: Relevance
“…All patients with DBS who are due for battery replacement should be counseled about the need to check battery status with the patient-controlled programmer and to contact the treating neurologist if the programmer shows the elective replacement indicator or end-of-service status. In PD, long-standing STN-DBS (> 5 years), advanced disease (> 15 years), low-dose dopaminergic medications and older age are risk factors for DBS withdrawal syndrome and should be a high priority for battery replacement in the case of battery exhaustion [ 6 , 7 ]. Urgent battery replacement or troubleshooting hardware malfunction is a high priority in most patients but should be decided on an individual basis after discussing the risk of complications, exposure risk to COVID-19 for both patients and healthcare workers and the availability of resources during the pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…All patients with DBS who are due for battery replacement should be counseled about the need to check battery status with the patient-controlled programmer and to contact the treating neurologist if the programmer shows the elective replacement indicator or end-of-service status. In PD, long-standing STN-DBS (> 5 years), advanced disease (> 15 years), low-dose dopaminergic medications and older age are risk factors for DBS withdrawal syndrome and should be a high priority for battery replacement in the case of battery exhaustion [ 6 , 7 ]. Urgent battery replacement or troubleshooting hardware malfunction is a high priority in most patients but should be decided on an individual basis after discussing the risk of complications, exposure risk to COVID-19 for both patients and healthcare workers and the availability of resources during the pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…This should be on a case-by-case basis, but non-urgent elective procedures: percutaneous endoscopic gastrostomy (PEG) for Duodopa, focused ultrasound thalamotomy (FUT), and deep brain stimulation (DBS) should be postponed, if and whenever possible. However, implantable pulse generator (IPG) battery replacements should still be performed because of the risks of the neuroleptic malignant syndrome with sudden battery failure (41).…”
Section: Parkinson's Disease and Other Movement Disordersmentioning
confidence: 99%
“…The syndrome has been associated with death [15]. The syndrome has only been reported in patients with bilateral STN DBS with at least 5 years of DBS therapy and more than 15 years of disease duration [16]. Additional risk factors include early age at disease onset, advanced symptoms at the time of initial surgery, and excellent DBS benefit leading to significant dopaminergic medication reduction [2].…”
Section: Parkinson's Diseasementioning
confidence: 99%